AZILSARTAN MEDOXOMIL PROPORTIONALLY DECREASES CENTRAL AND BRACHIAL 24-H AMBULATORY BLOOD PRESSURE IN DIABETIC PATIENTS WITH DIFFICULT-TO-CONTROL ARTERIAL HYPERTENSION